These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10896461)

  • 1. GP use of anti-D.
    Goulding C; Hamilton W
    Br J Fam Plann; 2000 Apr; 26(2):116. PubMed ID: 10896461
    [No Abstract]   [Full Text] [Related]  

  • 2. GP use of anti-D.
    Gilmour K
    Br J Fam Plann; 2000 Jul; 26(3):178. PubMed ID: 11001632
    [No Abstract]   [Full Text] [Related]  

  • 3. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-D (again!)--tell me the old, old story..
    Mitchell R
    Scott Med J; 1994 Oct; 39(5):138. PubMed ID: 8778967
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 7. The continuing struggle to eliminate hemolytic disease of the newborn from RH (D).
    Barlow JF
    S D J Med; 1999 Jan; 52(1):7-8. PubMed ID: 9926725
    [No Abstract]   [Full Text] [Related]  

  • 8. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR; Scofield TL; Moulds JJ; Swanson JL
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-evidence-based use of Rho(D) immune globulin for threatened abortion by family practice and obstetric faculty physicians.
    Weissman AM; Dawson JD; Rijhsinghani A; Honkamp NJ
    J Reprod Med; 2002 Nov; 47(11):909-12. PubMed ID: 12497679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Harding K
    Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perinatal hemolytic disease. Part 2: Prevention and management].
    Hohlfeld P; Wirthner D; Tissot JD
    J Gynecol Obstet Biol Reprod (Paris); 1998 Apr; 27(3):265-76. PubMed ID: 9648004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of immunoprophylaxis with anti-D immunoglobin.
    Engelfriet CP; Reesink HW; Judd WJ; Ulander VM; Kuosmanen M; Koskinen S; Rouger P; Morelati F; Tantalo V; Fujii T; de Haas M; van der Schoot CE; Overbeeke M; Koelewijn J; Bonsel G; Vrijkotte T; Zupańska B; Martin-Vega C; Parra Lopez R; de Silva M; Contreras M; Panzer S; Ulm B; Mayr WR
    Vox Sang; 2003 Nov; 85(4):328-37. PubMed ID: 14633261
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety of RhIG in the prevention of haemolytic disease of the newborn.
    Hirose TG; Mays DA
    J Obstet Gynaecol; 2007 Aug; 27(6):545-57. PubMed ID: 17896248
    [No Abstract]   [Full Text] [Related]  

  • 14. When should tests for unexpected antibodies be done during pregnancy?
    Judd WJ
    Transfusion; 2011 Jul; 51(7):1366-8. PubMed ID: 21736570
    [No Abstract]   [Full Text] [Related]  

  • 15. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy.
    Elasoud K; McClure G; Halliday HL; Dornan JC
    Ulster Med J; 1997 May; 66(1):62-4. PubMed ID: 9185494
    [No Abstract]   [Full Text] [Related]  

  • 17. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False positive Kleihauer-Betke (acid elution) test caused by elevated maternal fetal haemoglobin F cells.
    Donnelly JC; Cooley SM; Doyle A; Murphy D; Corcoran D; Kumpel B; Ní Ainle F
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():136-7. PubMed ID: 24192664
    [No Abstract]   [Full Text] [Related]  

  • 20. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden.
    Gottvall T; Filbey D
    Acta Obstet Gynecol Scand; 2008; 87(8):843-8. PubMed ID: 18704776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.